DeepMed Research

Xiyuan Hospital, China Academy of Chinese Medical Sciences

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Efficacy of YiQiFuMai Injection as an Adjunctive Treatment for Sepsis

Phase 4

Not yet recruiting

Conditions: Sepsis

Interventions: Drug: 0.9% Normal Saline 250ml
Drug: YiQiFuMai

First Posted Date: 2022-03-03

Last Posted Date: 2022-03-03

Lead Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

Target Recruit Count: 80

Registration Number: NCT05265130

Effect of Jianpi Huatan Decoction on Advanced Colorectal Cancer

Phase 3

Conditions: Colorectal Neoplasms

Interventions: Drug: Placebo granule
Drug: Jianpi Huatan dispensing granule

First Posted Date: 2022-01-11

Last Posted Date: 2022-01-11

Lead Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

Target Recruit Count: 200

Registration Number: NCT05187481

Locations: 🇨🇳
Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, Beijing, China

Clinical Study on Huatuo Zaizao Pills for Post-stroke Treatment

Phase 4

Completed

Conditions: Ischemic Stroke

Interventions: Drug: Huatuo Zaizao Pills
Other: Basic treatment

First Posted Date: 2021-06-02

Last Posted Date: 2024-11-28

Lead Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

Target Recruit Count: 80

Registration Number: NCT04910256

Locations: 🇨🇳
Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, China

Study on the Rule and Mechanism of Treating Functional Gastrointestinal Diseases From the Perspective of Liver and Spleen

Phase 4

Conditions: Non-erosive Reflux Disease/Diarrheal Irritable Bowel Syndrome

Interventions: Drug: The placebo of Chang 'an II Recipe
Drug: The placebo of tong-jiang granules
Drug: Chang 'an II Recipe
Drug: tong-jiang granules

First Posted Date: 2020-07-02

Last Posted Date: 2020-07-02

Lead Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

Target Recruit Count: 100

Registration Number: NCT04454996

Locations: 🇨🇳
Xiyuan Hospital of China Academy of Chinese Medical Science, Beijing, Beijing, China

The Role of Intestinal Flora in the Pathogenesis of FD and the Intervention of Xiangsha Liujunzi

Not Applicable

Conditions: Functional Dyspepsia

Interventions: Drug: Xiangsha Liujunzi granules

First Posted Date: 2020-06-29

Last Posted Date: 2020-06-29

Lead Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

Target Recruit Count: 90

Registration Number: NCT04449887

Locations: 🇨🇳
Digestive department of Xi Yuan Hospital of China Academy of Chinese Medical Sciences, Beijing, Beijing, China

Clinical Study on the Effect of Zhenyuan Capsule on Cardiopulmonary Function in Patients With SCAD

Phase 4

Conditions: Stable Coronary Heart Disease

Interventions: Drug: Zhenyuan capsule

First Posted Date: 2020-06-09

Last Posted Date: 2020-06-09

Lead Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

Target Recruit Count: 100

Registration Number: NCT04421287

Locations: 🇨🇳
Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China

Tongjiang Series Prescription Combined With PPIs Descending Ladder Withdrawal in Treating Nonerosive Reflux Disease

Phase 3

Conditions: Nonerosive Reflux Disease

Interventions: Drug: Tongjiang series prescription(Tongjiang granules, Jianpi Qinghua granules and Wenpi Qingwei granules)
Drug: Acid inhibitors
Drug: Placebo

First Posted Date: 2020-04-09

Last Posted Date: 2020-07-29

Lead Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

Target Recruit Count: 180

Registration Number: NCT04340297

Locations: 🇨🇳
Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China

Efficacy and Safety of Jianpi Qinghua Granules in Patients With Nonerosive Reflux Disease

Early Phase 1

Conditions: Nonerosive Reflux Disease

Interventions: Drug: Jianpi Qinghua placebo granules
Drug: Jianpi Qinghua granules

First Posted Date: 2020-03-27

Last Posted Date: 2021-04-08

Lead Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

Target Recruit Count: 78

Registration Number: NCT04324138

Locations: 🇨🇳
Xiyuan Hospital, Beijing, Beijing, China

Traditional Chinese Medicine for Severe COVID-19

Phase 3

Conditions: COVID-19

Interventions: Drug: Traditional Chinese Medicine Prescription

First Posted Date: 2020-03-26

Last Posted Date: 2020-03-26

Lead Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

Target Recruit Count: 50

Registration Number: NCT04323332

Locations: 🇨🇳
Hao Li, Beijing, Beijing, China

Efficacy and Safety of Modified Gegen Qinlian Decoction for Diarrhea-predominant Irritable Boewl Syndrome

Early Phase 1

Conditions: Diarrhea-predominant Irritable Boewl Syndrome

Interventions: Drug: Modified Gegen Qinlian Decoction

First Posted Date: 2020-03-18

Last Posted Date: 2020-03-18

Lead Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

Target Recruit Count: 60

Registration Number: NCT04312477

Locations: 🇨🇳
Xiyuanhospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy